Moolec Science SA Ordinary Shares (MLEC) is a publicly traded Healthcare sector company. As of May 21, 2026, MLEC trades at $7.26 with a market cap of $6.04M and a P/E ratio of 0.00. MLEC moved +0.00% today. Year to date, MLEC is +73.02%; over the trailing twelve months it is -94.67%. Its 52-week range spans $3.08 to $157.05. Rallies surfaces MLEC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Moolec Science Completes Idaho Planting and Identifies Genotypes with >60% GLA: Moolec Science wrapped up its 2026 commercial planting of GLASO1 safflower in Idaho’s American Falls region between May 4–14, leveraging optimized soil, irrigation and seed protocols. The company also identified 52 elite genotypes averaging over 60% GLA, surpassing the current 45% concentration benchmark to support future scale-up.
| Metric | Value |
|---|---|
| Price | $7.26 |
| Market Cap | $6.04M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $157.05 |
| 52-Week Low | $3.08 |
| Volume | 16 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
MLEC analyst coverage data. Average price target: $0.00.